These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 17956075)
1. FPIN's clinical inquiries. Best alternatives to statins for treating hyperlipidemia. Bouknight P; Mackler L; Heffington M Am Fam Physician; 2007 Oct; 76(7):1027-9. PubMed ID: 17956075 [No Abstract] [Full Text] [Related]
2. [Cardiovascular system drugs. 9/12. Antilipemics--II. Fibrates and colestyramine]. Nerich V; Limat S Soins; 2005; (692):57-8. PubMed ID: 15787412 [No Abstract] [Full Text] [Related]
3. Three new drugs for hyperlipidemia. Med Lett Drugs Ther; 2003 Mar; 45(1151):17-9. PubMed ID: 12612501 [No Abstract] [Full Text] [Related]
4. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates. Dominiczak M Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712 [No Abstract] [Full Text] [Related]
5. Three new drugs for hyperlipidemia. Conn Med; 2003 May; 67(5):279-81. PubMed ID: 12802842 [No Abstract] [Full Text] [Related]
6. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins? Goumas GS Angiology; 2009; 60(1):93-8. PubMed ID: 19019838 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of dyslipidemia in post-infarction: state of the art]. Borgia MC; Nardi M; Da Ros S; Castellano V Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719 [TBL] [Abstract][Full Text] [Related]
8. Drug treatment of lipid disorders. Knopp RH N Engl J Med; 1999 Aug; 341(7):498-511. PubMed ID: 10441607 [No Abstract] [Full Text] [Related]
9. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia and cardiovascular disease management. Codario RA J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282 [No Abstract] [Full Text] [Related]
11. Rationale for combination therapy with statin drugs in the treatment of dyslipidemia. Ansell BJ Curr Atheroscler Rep; 2005 Feb; 7(1):29-33. PubMed ID: 15683599 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effects of bezafibrate in hyperlipidemia]. Kunesová M; Honková M; Zeman M; Mares P; Skorepa J Cas Lek Cesk; 1983 May; 122(20):628-31. PubMed ID: 6342789 [No Abstract] [Full Text] [Related]
13. [Hypolipidemic activity of glycine and its derivatives]. Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998 [TBL] [Abstract][Full Text] [Related]
14. Lipid management in the geriatric patient. Nair AP; Darrow B Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519 [TBL] [Abstract][Full Text] [Related]
15. [Influence polyunsaturated fatty acids omega-3 on coagulation and fibrinolysis systems in patients with NIDDM]. Panchenko VM; Karabasova MA; Liutova LV; Togoev AM; Ershov AA; Chernova GI; Isaev VA Klin Med (Mosk); 2002; 80(2):40-3. PubMed ID: 11898721 [TBL] [Abstract][Full Text] [Related]
16. The use of lipid-lowering drug therapy in children and adolescents. Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879 [TBL] [Abstract][Full Text] [Related]
17. On the road to better dyslipidemia outcomes. Hughes S Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874 [No Abstract] [Full Text] [Related]
18. [Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia]. Janka HU; Standl A; Holler HD; Mehnert H MMW Munch Med Wochenschr; 1982 May; 124(21):535-7. PubMed ID: 6810123 [No Abstract] [Full Text] [Related]
19. Managing dyslipidemia in chronic kidney disease. Harper CR; Jacobson TA J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393 [TBL] [Abstract][Full Text] [Related]